Last Updated on August 30, 2023
Biopharma companies, including Sanofi, AbbVie and Virax Biolabs, are finding significant business opportunities in the Middle East, particularly in the United Arab Emirates and Saudi Arabia. These countries have emerged as attractive markets for novel therapies, driven by growing populations with increasing incidences of chronic diseases such as diabetes and cardiovascular diseases.
Our opinion: To start engagement with HCPs in these countries data protection laws such as PDPL are applicable. Once you start collecting personal data of HCPs be aware of the fact that you to have comply with these laws to be compliant ensure trusted engagement with the targetgroup.